For many patients with refractory headache, ketamine treatment may provide short-term analgesia with tolerable adverse events.
A panel of experts formulated consensus guidelines for physicians who use intravenous ketamine infusions to treat chronic pain.
Consensus guidelines regarding the use of ketamine for the management of acute pain have been approved.
Ketamine infusion may provide short-term pain relief for patients with complex regional pain syndrome.
Acute pain management in the emergency department with low-dose ketamine may provide pain relief comparable with morphine at 30 minutes.
Current evidence suggests ketamine may be an effective therapy for the management of chronic noncancer pain.
Ketamine is associated with significant pain relief among patients with refractory headaches.
Ketamine was found to alleviate several pain modalities, and a number of clinical trials investigating its efficacy are ongoing.
Ketamine may alleviate depression, pain, and adverse effects associated with opioid treatment, and may thus represent an attractive adjunct therapy for pain management.
A ketamine regimen is superior to methadone, or ketamine combined with methadone, in alleviating neuropathic pain and associated sensory changes.
A combination of ketamine infusion treatment and psychotherapy was found to attenuate PTSD manifestation and reduce pain scores.
Often, family and friends cannot appreciate the depth of pain and suffering that depression can cause.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics